Guggenheim analyst Charles Zhu assumes coverage on Protera Therapeutics (NASDAQ: TARA) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE